These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35620675)
1. Hyperammonemia After Lung Transplantation: Systematic Review and a Mini Case Series. Kamel AY; Emtiazjoo AM; Adkins L; Shahmohammadi A; Alnuaimat H; Pelaez A; Machuca T; Pipkin M; Lee HW; Weiner ID; Chandrashekaran S Transpl Int; 2022; 35():10433. PubMed ID: 35620675 [No Abstract] [Full Text] [Related]
2. Hyperammonemia Syndrome After Lung Transplantation: A Single Center Experience. Chen C; Bain KB; Iuppa JA; Yusen RD; Byers DE; Patterson GA; Trulock EP; Hachem RR; Witt CA Transplantation; 2016 Mar; 100(3):678-84. PubMed ID: 26335916 [TBL] [Abstract][Full Text] [Related]
3. Idiopathic hyperammonemia after solid organ transplantation: Primarily a lung problem? A single-center experience and systematic review. Krutsinger D; Pezzulo A; Blevins AE; Reed RM; Voigt MD; Eberlein M Clin Transplant; 2017 May; 31(5):. PubMed ID: 28295601 [TBL] [Abstract][Full Text] [Related]
4. Hyperammonemia syndrome post-lung transplantation: Case series and systematic review of literature. Buzo BF; Preiksaitis JK; Halloran K; Nagendran J; Townsend DR; Zelyas N; Sligl WI Transpl Infect Dis; 2022 Dec; 24(6):e13940. PubMed ID: 36039822 [TBL] [Abstract][Full Text] [Related]
5. Successful management of immunosuppression in a patient with severe hyperammonemia after lung transplantation. Moffatt-Bruce SD; Pesavento T; Von Viger J; Nunley D; Pope-Harman A; Martin S; Ross P J Heart Lung Transplant; 2008 Jul; 27(7):801-3. PubMed ID: 18582813 [TBL] [Abstract][Full Text] [Related]
14. Fatal hyperammonemia and carbamoyl phosphate synthetase 1 (CPS1) deficiency following high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Laemmle A; Hahn D; Hu L; Rüfenacht V; Gautschi M; Leibundgut K; Nuoffer JM; Häberle J Mol Genet Metab; 2015 Mar; 114(3):438-44. PubMed ID: 25639153 [TBL] [Abstract][Full Text] [Related]
15. Extracorporeal Liver Support for the Treatment of Hyperammonemia After Lung Transplantation. Kwon M; Alvarez F; Moreno Franco P; Patel A; Canabal JM; Haddad TJ; Erasmus DB; Mallea JM; Narula T Transplantation; 2020 Mar; 104(3):e75-e76. PubMed ID: 31385932 [No Abstract] [Full Text] [Related]
16. Threshold for toxicity from hyperammonemia in critically ill children. Ozanne B; Nelson J; Cousineau J; Lambert M; Phan V; Mitchell G; Alvarez F; Ducruet T; Jouvet P J Hepatol; 2012 Jan; 56(1):123-8. PubMed ID: 21703182 [TBL] [Abstract][Full Text] [Related]
17. Pathophysiology and Management of Hyperammonemia in Organ Transplant Patients. Seethapathy H; Fenves AZ Am J Kidney Dis; 2019 Sep; 74(3):390-398. PubMed ID: 31040091 [TBL] [Abstract][Full Text] [Related]
19. Hyperammonemia in lung transplant patients and its management: a review. Kumar A; Advani S; Asim K; Mohamed MA; Wani F; Singh J; Albosta M; Shiwalkar N; Keshavamurthy S Indian J Thorac Cardiovasc Surg; 2022 Jul; 38(Suppl 2):335-346. PubMed ID: 35756952 [TBL] [Abstract][Full Text] [Related]
20. Correction and Control of Hyperammonemia in Acute Liver Failure: The Impact of Continuous Renal Replacement Timing, Intensity, and Duration. Warrillow S; Fisher C; Bellomo R Crit Care Med; 2020 Feb; 48(2):218-224. PubMed ID: 31939790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]